Role of adjuvant therapy in resected stage IA subcentimeter (T1a/T1b) pancreatic cancer

ConclusionsThe current study is the first to demonstrate no survival benefit for adjuvant therapy in patients with resected subcentimeter PDAC.

Source: Cancer - November 20, 2018 Category: Cancer & Oncology Authors: Walid L. Shaib, Amit Surya Narayan, Jeffrey M. Switchenko, Sujata R. Kane, Christina Wu, Mehmet Akce, Olatunji B. Alese, Pretesh R. Patel, Shishir K Maithel, Juan M. Sarmiento, David A. Kooby, Bassel F. El ‐Rayes Tags: Original Article Source Type: research